Drugs belonging to class 'Tyrosine kinase inhibitor'

See adverse reactions attributed to class 'Tyrosine kinase inhibitor'

Drug NameCompare
Afatinibcompare
Axitinibcompare
Bosutinibcompare
Brigatinibcompare
Cabozantinibcompare
Crizotinibcompare
Dasatinibcompare
Erdafitinibcompare
Erlotinibcompare
Gefitinibcompare
Imatinibcompare
Lapatinibcompare
Leflunomidecompare
Lenvatinibcompare
Nilotinibcompare
Nintedanibcompare
Pazopanibcompare
Ponatinibcompare
Regorafenibcompare
Sorafenibcompare
Sunitinibcompare
Vandetanibcompare

 

Adverse reactions attributed to entire drug class 'Tyrosine kinase inhibitor'

Please login to view adverse reactions

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric